Top Markets
Coin of the day
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Classement en actions #2605
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Prix de l'action
$27.75
Capitalisation boursière
$7.84B
Changement (1 jour)
6.21%
Changement (1 an)
-27.88%
Pays
US
Échange Caris Life Sciences, Inc. (CAI)

Catégorie

EPS pour Caris Life Sciences, Inc. (CAI)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Caris Life Sciences, Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Caris Life Sciences, Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH